In8Bio Balance Sheet (2020-2026)

Reported Financials

In8Bio Quarterly Balance Sheet

Periods 25 quarters

Latest Jun 2026

In8Bio reported total assets of $21.75M and total liabilities of $3.38M for the quarter ended Jun 2026, up 12.3% year over year. This balance sheet covers 25 quarters of results from Jun 2020 through Jun 2026, standardized by Business Quant from the company’s SEC filings.

Balance Sheet	Sep2021	Dec2021	Mar2022	Jun2022	Sep2022	Dec2022	Mar2023	Jun2023	Sep2023	Dec2023	Mar2024	Jun2024	Sep2024	Dec2024	Mar2025	Jun2025	Sep2025	Dec2025	Mar2026	Jun2026
Accumulated Depreciation	0.32M	0.35M	0.36M	0.38M	0.42M	0.32M	0.56M	0.81M	1.05M	1.28M	1.52M	1.76M	2.01M	2.26M	2.52M			3.20M	3.44M
Assets
Current Assets
Cash & EquivalentsCash & Equiv.	40.67M	37.27M	32.36M	25.99M	27.90M	18.43M	10.86M	16.99M	12.85M	21.54M	13.02M	10.48M	4.26M	11.39M	11.89M	13.50M	10.96M	27.31M	21.94M	18.13M
Prepaid Assets	3.20M	1.96M	1.17M	1.26M	2.01M	4.05M	3.54M	2.47M	3.69M	3.34M	2.74M	2.46M	2.70M	1.46M	0.84M	0.52M	1.08M	0.79M	0.72M	0.54M
Current Assets	43.88M	38.98M	33.27M	27.00M	29.65M	22.23M	14.40M	19.46M	16.55M	24.62M		12.68M	6.70M	12.58M	12.72M	13.74M	11.77M	27.88M	22.66M	18.50M
Non-Current Assets
Construction in Progress	0.18M	0.40M	0.50M
Property, Plant & Equipment (Net)	0.30M	0.10M	0.24M	0.22M	0.35M	4.40M	4.20M	3.98M	3.74M	3.51M	3.33M	3.11M	3.08M	2.86M	2.60M	2.35M	2.10M	1.86M	1.62M	1.60M
Long-Term Deferred Tax										2.70M
Other Non-Current Assets	0.25M	0.25M	0.25M	0.25M	0.25M	0.26M	0.25M	0.25M	0.25M	0.26M	0.26M	0.26M	0.26M	0.28M	0.27M	0.27M	0.27M	0.22M	0.22M	0.18M
Non-Current Assets	3.26M	3.24M	3.26M	3.99M	8.73M	10.80M	10.28M	10.25M	9.66M	9.08M		9.81M	9.26M	8.37M	7.14M	5.63M	5.00M	4.40M	3.60M	3.25M
Assets	47.13M	42.22M	36.54M	30.99M	38.38M	33.04M	24.68M	29.72M	26.21M	33.71M		22.50M	15.97M	20.94M	19.87M	19.37M	16.77M	32.28M	26.27M	21.75M
Liabilities
Current Liabilities
Accounts Payables	0.69M	0.40M	0.55M	0.89M	1.11M	2.09M	0.87M	0.58M	0.75M	0.92M		1.44M	1.14M	0.39M	0.57M	0.38M	0.20M	0.31M	0.45M	0.44M
Payables	0.69M	0.40M	0.55M	0.89M	1.11M	2.09M	0.87M	0.58M	0.75M	0.92M		1.44M	1.14M	0.39M	0.57M	0.38M	0.20M	0.31M	0.45M	0.44M
Accumulated Expenses	0.84M	1.24M	0.88M	1.52M	2.88M	2.34M	1.49M	1.67M	2.44M	2.96M	0.90M	1.53M	0.77M	1.05M	1.15M	0.64M	0.42M	1.63M	0.68M	0.76M
Other Accumulated Expenses	0.20M	0.05M	0.36M	0.43M	0.29M	0.42M	0.41M	0.39M	0.32M	0.36M	0.18M	0.28M	0.14M	0.13M	0.23M	0.06M	0.01M	0.06M	0.06M	0.02M
Short term Debt
Current Leases	0.46M	0.39M	0.33M	0.30M	0.64M	0.71M	0.73M	0.77M	0.78M	0.82M	0.86M	0.90M	0.92M	0.95M	0.66M	0.54M	0.74M	0.92M	0.84M	0.92M
Total Current Liabilities	2.16M	2.26M	2.07M	2.97M	4.90M	5.82M	3.75M	3.78M	4.69M	5.39M		4.76M	3.63M	3.08M	2.96M	1.95M	1.70M	3.16M	2.16M	2.25M
Non-Current Liabilities
Capital Leases	0.34M	0.27M	0.20M	0.13M	0.07M	0.81M	0.66M	0.86M	0.69M	0.53M	0.35M	0.53M	0.40M	0.29M	0.19M	0.13M	0.06M
Non-Current Deffered Revenue
Preferred Stock Liabilities
Operating Leases	1.59M	1.51M	1.43M	1.32M	3.85M	3.67M	3.48M	3.28M	3.07M	2.85M	3.83M	3.59M	3.34M	3.09M	2.85M	2.05M	1.81M	1.56M	1.33M	1.13M
Non-Current Deferred Tax Liability						9.80M
Total Non-Current Liabilities		1.78M	1.64M	1.45M	3.92M	4.49M	4.14M	4.14M	3.76M	3.38M		4.12M	3.74M	3.38M	3.04M	2.18M	1.88M	1.56M	1.33M	1.13M
Total Liabilities	4.10M	4.04M	3.70M	4.42M	8.82M	10.31M	7.89M	7.92M	8.45M	8.77M	-490.00M	8.88M	7.38M	6.47M	5.99M	4.13M	3.58M	4.72M	3.48M	3.38M
Shareholder's Equity
Total Debt
Common Equity	43.04M	-38.18M	32.84M	26.57M	29.56M	22.73M	16.79M	21.80M	17.76M	24.94M	490.00M	13.62M	8.59M	14.48M	13.88M	15.24M	13.19M	27.56M	22.78M	18.36M
Liabilities and Shareholders Equity	47.13M	42.22M	36.54M	30.99M	38.38M	33.04M	24.68M	29.72M	26.21M	33.71M		22.50M	15.97M	20.94M	19.87M	19.37M	16.77M	32.28M	26.27M	21.75M
Retained Earnings	69.88M	70.87M	71.67M	72.58M	82.97M	83.94M	85.52M	98.25M	101.38M	116.15M	99.80M	122.03M	124.08M	136.13M	141.07M	147.53M	149.33M	168.64M	168.96M	169.32M
Treasury Shares

In8Bio INAB Balance Sheet (2020-2026)

In8Bio Quarterly Balance Sheet

Create an account

Sign In

Reset Password